Beneficial Effect of Omega-3 Fatty Acids on Sirolimus- or Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients-Reference-Cited by-同舟云学术

Beneficial Effect of Omega-3 Fatty Acids on Sirolimus- or Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients

Published:2008-07-27 Issue:2 Volume:86 Page:245-250
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Celik Sultan,Doesch Andreas,Erbel Christian,Blessing Erwin,Ammon Kerstin,Koch Achim,Katus Hugo A.,Dengler Thomas J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference50 articles.

1. Atherosclerosis is an inflammatory disease.;Ross;Am Heart J,1999

2. Hyperlipidemia in solid organ transplantation.;Kobashigawa;Transplantation,1997

3. Pathophysiology and treatment of lipid perturbation after cardiac transplantation.;Ballantyne;Curr Opin Cardiol,1997

4. A randomized active- controlled trial of mycophenolate mofetil in heart transplant recipients.;Kobashigawa;Transplantation,1999

5. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection.;Meiser;J Heart Lung Transplant,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus-induced Hypertriglyceridemia Leads to Acute Pancreatitis and Diabetic Ketoacidosis Post Stem Cell Transplant for Sickle Cell Disease;Journal of Pediatric Hematology/Oncology;2023-11-30

2. New Approaches to Cardiovascular Disease and its Management in Kidney Transplant Recipients;Transplantation;2021-11-29

3. Post-transplant Management in Heart Transplant Recipients: New Drugs and Prophylactic Strategies;Current Treatment Options in Cardiovascular Medicine;2021-06-03

4. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations;Vascular and Endovascular Surgery;2021-04-21

5. Lipid lowering treatment of severe hypertriglyceridemia with acute pancreatitis caused by everolimus in a patient with a neuroendocrine tumor;Anales del Sistema Sanitario de Navarra;2020-04-20